Decline in hepatitis B infection observed after 11 years of regional vaccination among Danish drug users

Journal of Medical Virology

Volumn 82, Issue 10, 2010, Pages 1635-1639

  Mossner B K ^a   Skamling, M ^b   Jorgensen T R ^c   Georgsen, J ^a   Pedersen, C ^a   Christensen, P B ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Treatment Center Svendborg   (Denmark)

^c Treatment Center Odense   (Denmark)

Author keywords

Hepatitis C; HIV; Prevalence

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE; HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; DRUG USE; FEMALE; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; VACCINATION; ADDICTION; BLOOD; CROSS-SECTIONAL STUDY; DENMARK; HEPATITIS C VIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; CROSS-SECTIONAL STUDIES; DENMARK; DRUG USERS; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RNA, VIRAL; SUBSTANCE-RELATED DISORDERS;

EID: 77956583599     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21836     Document Type: Article

References (17)

1. Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP. 2008. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: A 15-year follow-up study. Pediatr Infect Dis J 27:881-885.
2. But DY, Lai CL, Lim WL, Fung J, Wong DK, Yuen MF. 2008. Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report. Vaccine 26:6587-6591.
3. Christensen PB. 1999. Bloodborne viral infections in Funen - A seroepidemiologic study. Denmark: University of Southern Denmark, pp. 1-142.
4. Christensen PB, Krarup HB, Niesters HG, Norder H, Georgsen J. 2000. Prevalence and incidence of bloodborne viral infections among Danish prisoners. Eur J Epidemiol 16:1043-1049.
5. Christensen PB, Krarup HB, Niesters HG, Norder H, Schaffalitzky de Muckadell OB, Jeune B, Georgsen J. 2001. Outbreak of hepatitis B among injecting drug users in Denmark. J Clin Virol 22:133-141.
6. Christensen PB, Kringsholm B, Banner J, Thomsen JL, Cowan S, Stein GF, Jurgensen GW, Grasaasen K, Georgsen J, Pedersen C. 2006a. Surveillance of HIV and viral hepatitis by analysis of samples from drug related deaths. Eur J Epidemiol 21:383-387.
7. Christensen PB, Hammerby E, Smith E, Bird SM. 2006b. Mortality among Danish drug users released from prison. Int J Prisoner Health 2:13-19.
8. Dentinger CM, McMahon BJ, Butler JC, Dunaway CE, Zanis CL, Bulkow LR, Bruden DL, Nainan OV, Khristova ML, Hennessy TW, Parkinson AJ. 2005. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J 24:786-792.
9. Fuglsang T, Fouchard JR, Ege PP. 2000. Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen. Ugeskr Laeger 162:3860-3864.
10. Harpaz R, McMahon BJ, Margolis HS, Shapiro CN, Havron D, Carpenter G, Bulkow LR, Wainwright RB. 2000. Elimination of new chronic hepatitis B virus infections: Results of the Alaska immunization program. J Infect Dis 181:413-418.
11. Krarup HB, Drewes AM, Madsen PH. 1998. A quantitative HCV-PCR test for routine diagnostics. Scand J Clin Lab Invest 58:415-422.
12. Krarup HB, Andersen S, Madsen PH, Okkels H, Hvingel BH, Laurberg P. 2008. Benign course of long-standing hepatitis B virus infection among Greenland Inuit? Scand J Gastroenterol 43:334-343.
13. Levine OS, Vlahov D, Nelson KE. 1994. Epidemiology of hepatitis B virus infections among injecting drug users: Seroprevalence, risk factors, and viral interactions. Epidemiol Rev 16:418-436.
14. Lohse N, Hansen AB, Jensen-Fangel S, Kronborg G, Kvinesdal B, Pedersen C, Larsen CS, Moller A, Willumsen L, Obel N. 2005. Demographics of HIV-1 infection in Denmark: Results from the Danish HIV Cohort Study. Scand J Infect Dis 37:338-343. (Pubitemid 40691514)
15. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS. 2005. Antibody levels and protection after hepatitis B vaccination: Results of a 15-year follow-up. Ann Intern Med 142:333-341.
16. van der Sande MA, Waight P, Mendy M, Rayco-Solon P, Hutt P, Fulford T, Doherty C, McConkey SJ, Jeffries D, Hall AJ, Whittle HC. 2006. Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis 193:1528-1535.
17. Westh H, Worm AM, Jensen BL, Kroon S, Kvinesdal B, Nielsen CM, Wantzin P. 1993. Hepatitis C virus antibodies in homosexual men and intravenous drug users in Denmark. Infection 21:115-117.